Skip to main content

Nonprofit · EIN 88-3068255

SECUREBIO INC

Tax-exempt · CAMBRIDGE, MA 02142

Financials

$4.3M$2.9M2023$7.3M$4.3M2024
Revenue Expenses · by fiscal year end
Financials of SECUREBIO INC by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990$7,324,329$4,251,865$3,072,464$8,470,365$682,712$7,787,653
December 31, 2023990 (amended)$4,319,125$2,853,790$1,465,335$4,855,240$140,051$4,715,189
Financial details: 990 for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$6,816,844
Program service revenue
$326,249
Investment income
$174,336
Other revenue
$6,900

Expenses

Grants and similar amounts paid
$97,000
Compensation of officers, directors and key employees
$209,958
Other salaries and wages
$986,809
Salaries, compensation and benefits (total)
$1,372,932
Professional fundraising fees
$0
Legal fees
$154,901
Accounting fees
$38,877
Occupancy
$18,191
Travel
$53,244
Depreciation
$202,079
Program services (functional)
$3,386,059
Management and general (functional)
$865,806

Balance sheet and other

Total assets, start of year
$4,855,240
Total assets, end of year
$8,470,365
Total liabilities, end of year
$682,712
Net assets, end of year
$7,787,653
Land, buildings and equipment
$665,732
Net assets without donor restrictions
$4,306,710
Net assets with donor restrictions
$3,480,943
Gross receipts
$7,324,329
Employees
16
Year formed
2022
State of legal domicile
DE

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensationOther / benefits
Jeffrey KaufmanNAO Project Lead40$145,000$6,815
Michael McLarenResearch Scientist40$138,299$12,116
William BradshawSecretary
Officer
40$121,513$10,347
Seth DonougheResearch Scientist40$122,747$4,225
Daniel RiceResearch Scientist40$113,672$5,207
Benjamin Mueller Treas Sep-DecExecutive Dir.
Trustee or director, Officer
15$53,175$0
Vaishnav Sunil Treas Jan-SepTreasurer
Officer
15$24,397$526
Kevin EsveltDirector
Trustee or director
0.5$0$0
Sawyer BernathDirector
Trustee or director
2$0$0
Liv BoereeDirector
Trustee or director
1$0$0
Michael SpecterDirector
Trustee or director
1$0$0
Christine ParthemoreDirector
Trustee or director
1$0$0
990 for the year ended December 31, 2023: 8 people
NameTitleHours / weekCompensationOther / benefits
Jeffrey KaufmanNAO Project Lead40$144,989$5,364
Tiffany TzengOperations Manager40$116,071$12,469
Daniel RiceResearch Scientist40$119,826$4,556
Vaishnav SunilTreasurer
Officer
4$8,400$0
Benjamin MuellerExecutive Dir.
Trustee or director, Officer
1$0$0
Kevin EsveltDirector
Trustee or director
0.5$0$0
Sawyer BernathDirector
Trustee or director
0.5$0$0
William BradshawSecretary
Officer
4$0$0

Address and contacts

Address (IRS master file)
1 BROADWAY 13-100, CAMBRIDGE, MA 02142-1100
In care of
% PROF KEVIN ESVELT E15-35
Principal officer (990 for 2024)
Benjamin Mueller
Signed the 990
Benjamin Mueller, Executive Director
Phone
(615) 379-8149
Return prepared by
Tovella Dowling PC

Mission

To reduce catastrophic risks from novel biotechnologies by conducting research on pandemic prevention, detection, and mitigation.

990 for the year ended December 31, 2024

Program accomplishments

  • As part of its work on the Nucleic Acid Observatory NAO project, the organization runs experiments to detect metagenomic sequences in wasterwater, with the ultimate aim of detecting new diseases before they grow exponentially in the community. In 2024, The NAO team conducted real-world biosurveillance of metropolitan sewage and airplane wastewater samples from selected US airports. It expects to scale its detection efforts in 2025.
    Expenses $1,454,990
  • As part of its SecureDNA project, the organization continued to make significant progress in 2024 on its gene synthesis screening software. The team released an alpha version and prepared for a public beta launch. This free software offers best-in-class performance in screening criteria and runs against a continuously updated hazard database. SecureDNA uniquely integrates with both vendor order flows and benchtop synthesizers. The organization successfully tested with major manufacturers and collaborated with leading gene synthesis companies. Two papers were prepared for submission to peer-reviewed journals, one on the screening system and another on its cryptographic architecture. These advancements further the organization's goal of securely monitoring synthetic DNA orders against various public health hazards.
    Expenses $1,135,237
  • The organization is developing measurement tools to assess AI systems' potential contribution to global catastrophic biological risks and creating mitigation strategies for when AI capabilities cross specific risk thresholds. Working with government and industry partners, they aim to de-risk upcoming AI model releases against severe biological hazards. The team has already published a pre-print on biorisks associated with model weight proliferation in Large Language Models, garnering major media attention. Their ongoing projects include research on risks from frontier models, developing benchmarks to evaluate large language models' biosecurity-relevant capabilities, creating task-based assessments for frontier systems' autonomous capabilities, and implementing technical interventions for risk mitigation, such as model unlearning of dual-use biological concepts and enhancing adversarial robustness against dual-use input prompts.
    Expenses $748,527 · revenue $326,249
  • The organization focuses on pandemic-proof personal protective equipment PPE that reliably shields essential workers against highly infectious agents without requiring fit-testing, ensuring the maintenance of critical infrastructure during pandemics. To enhance the availability and accessibility of this crucial equipment, the organization has undertaken several key initiatives. These include mapping critical infrastructure and essential workers, identifying cost-reduction strategies, advocating for public funds to build and maintain stockpiles, and exploring market mechanisms to support government efforts in stockpiling pandemic-proof PPE. Through these activities, the organization aims to strengthen pandemic preparedness and protect those who must continue working during health crises.
    Expenses $47,305
  • As part of its work on the FAR-UVC project, the organization conducted an in-depth examination of the safety of far-UVC germicidal light throughout 2023. This comprehensive study involved convening a group of experts for both in-person and remote workshops over a 12-month period. The culmination of this extensive research was the release of a major paper on far-UVC safety, effectively concluding the organization's work on this project. While the organization designed a clinical study to further investigate the application of far-UVC technology, it determined that executing such a trial was not feasible given the available resources. This decision marked the completion of the organization's active involvement in the FAR-UVC research initiative.

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Not on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
88-3068255
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2022
Accounting year ends
December
Files
Form 990 or 990-EZ
Assets (IRS master file)
$8,470,365
Income (IRS master file)
$7,324,329

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2024$7,324,329$4,251,865$8,470,365XML
990December 2023$4,319,125$2,853,790$4,855,240XML
990December 2022$3,436,133$186,279$3,261,854IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 88-3068255).

Questions about SECUREBIO INC

What is the EIN of SECUREBIO INC?
The employer identification number (EIN) of SECUREBIO INC is 88-3068255.
Is SECUREBIO INC tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2022.
Are donations to SECUREBIO INC tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does SECUREBIO INC file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of SECUREBIO INC due?
The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did SECUREBIO INC last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2024.
Who is the principal officer of SECUREBIO INC?
The 990 for the year ended December 31, 2024 names Benjamin Mueller.
Who are the officers and directors of SECUREBIO INC?
The 990 for the year ended December 31, 2024 lists 12 people; 7 received compensation from the organization, the highest $145,000 (Jeffrey Kaufman, NAO Project Lead).
How much revenue does SECUREBIO INC have?
On its 990 for the year ended December 31, 2024 it reported revenue of $7,324,329, expenses of $4,251,865 and total assets of $8,470,365 at year end.

Other nonprofits in CAMBRIDGE

All nonprofits in CAMBRIDGE · Massachusetts · Science and technology